From public campaigns featuring Cyndi Lauper to ads with dinosaurs, MM+M compiles the best public marketing campaigns from ...

Patients would pay no more than $25 for certain name-brand medications to treat chronic illnesses, and face no costs for ...

The bill would add scrutiny to pharmacy benefit managers and eliminate or cap out-of-pocket costs for drugs that treat ...

Navigating the large universe of small-cap stocks can be a daunting task, which is why most investors leave the stock picking ...

Asthma inhalers are hand-held devices that allow ... Within each class of inhaled asthma medication are different drugs with ...

Aptar, Clearway Energy, and Darling are among sustainable holdings. Finding the small-cap stocks that are uniquely owned by ...

A collaboration between a drug plan and clinical pharmacists led to nearly 50% of members successfully switching to a preferred dipeptidyl-peptidase-4 inhibitor.

The selected name-brand drug wouldn't be subject to any deductible ... mechanisms" to manage chronic illnesses – like needles, inhalers and monitors – was not included in the final compromise ...

The selected name brand drug won’t be subject to any deductible ... mechanisms” to manage chronic illnesses, like needles, inhalers and monitors, was not included in the final compromise ...

This is great news for people with COPD or asthma, who can now pay only $35 for certain inhalers. And for people with ...